SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001267602-24-000027
Filing Date
2024-04-29
Accepted
2024-04-29 17:21:58
Documents
15
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A alim-20231231x10ka.htm   iXBRL 10-K/A 1472147
2 EX-31.1 alim-20231231xex31_1.htm EX-31.1 9748
3 EX-31.2 alim-20231231xex31_2.htm EX-31.2 9792
  Complete submission text file 0001267602-24-000027.txt   1778048

Data Files

Seq Description Document Type Size
4 EX-101.SCH alim-20231231.xsd EX-101.SCH 2158
5 EX-101.LAB alim-20231231_lab.xml EX-101.LAB 30541
6 EX-101.PRE alim-20231231_pre.xml EX-101.PRE 18138
18 EXTRACTED XBRL INSTANCE DOCUMENT alim-20231231x10ka_htm.xml XML 8280
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34703 | Film No.: 24892878
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)